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Abstract
Human implantation involves extensive tissue remodeling at the fetal-maternal interface. It is becoming increasingly evident
that not only trophoblast, but also decidualizing endometrial stromal cells are inherently motile and invasive, and likely
contribute to the highly dynamic processes at the implantation site. The present study was undertaken to further
characterize the mechanisms involved in the regulation of endometrial stromal cell motility and to identify trophoblast-
derived factors that modulate migration. Among local growth factors known to be present at the time of implantation,
heparin-binding epidermal growth factor-like growth factor (HB-EGF) triggered chemotaxis (directed locomotion), whereas
platelet-derived growth factor (PDGF)-BB elicited both chemotaxis and chemokinesis (non-directed locomotion) of
endometrial stromal cells. Supernatants of the trophoblast cell line AC-1M88 and of first trimester villous explant cultures
stimulated chemotaxis but not chemokinesis. Proteome profiling for cytokines and angiogenesis factors revealed neither
PDGF-BB nor HB-EGF in conditioned media from trophoblast cells or villous explants, while placental growth factor, vascular
endothelial growth factor and PDGF-AA were identified as prominent secretory products. Among these, only PDGF-AA
triggered endometrial stromal cell chemotaxis. Neutralization of PDGF-AA in trophoblast conditioned media, however, did
not diminish chemoattractant activity, suggesting the presence of additional trophoblast-derived chemotactic factors.
Pathway inhibitor studies revealed ERK1/2, PI3 kinase/Akt and p38 signaling as relevant for chemotactic motility, whereas
chemokinesis depended primarily on PI3 kinase/Akt activation. Both chemotaxis and chemokinesis were stimulated upon
inhibition of Rho-associated, coiled-coil containing protein kinase. The chemotactic response to trophoblast secretions was
not blunted by inhibition of isolated signaling cascades, indicating activation of overlapping pathways in trophoblast-
endometrial communication. In conclusion, trophoblast signals attract endometrial stromal cells, while PDGF-BB and HB-
EGF, although not identified as trophoblast-derived, are local growth factors that may serve to fine-tune directed and non-
directed migration at the implantation site.
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Introduction
In humans, blastocyst implantation and hemochorial placenta-
tion are highly invasive and dynamic processes. Diverse tropho-
blast populations arising from the trophectodermal shell of the
blastocyst are in intimate crosstalk with the maternal decidua. The
tips of anchoring villi harbor cell columns consisting of prolifer-
ating cytotrophoblast cells (CTB). These give rise to extravillous
trophoblast cells (EVT) as they break through the syncytiotropho-
blast covering the villi. Interstitial EVT invade the decidua as far
as into the inner third of the myometrium, while endovascular
EVT migrate into the uterine spiral arteries, displace the
endothelial cells and remodel the vessels to establish increased
blood flow into the intervillous space to support embryo
development. Insufficient invasion is thought to contribute to
severe pregnancy complications like preeclampsia and intra-
uterine growth retardation [1–5]. The invasive capacity of EVT
has been extensively studied, revealing a multitude of pathways
involved in its regulation [6]. Chemotactic gradients are believed
to direct invasion, and a balance of local proteases and protease
inhibitors limits the extent of invasion in a temporal and spatial
fashion [7–9].
Proper decidualization of endometrial stromal cells is critical to
the establishment of pregnancy. The decidualization process is
initiated in the mid-secretory phase of the menstrual cycle,
independently of the presence of a blastocyst, and involves
transformation of the elongated fibroblast-like endometrial stromal
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cells to larger cobblestone shaped secretory decidual cells [10].
Extensive reprogramming of the endometrial stromal cell gene
expression profile upon decidualization results in altered cytoskel-
etal organization, extracellular matrix composition and adhesion,
secretion of and responses to growth factors, cytokines and
chemokines, and increased resistance to oxidative stress [11–13].
Downregulation of a-smooth muscle actin (a-SMA) causes a
disruption of the cytoskeleton associated with morphological
transformation [14]. Typical decidual marker genes are PRL and
IGFBP1 which are activated in response to cAMP and progester-
one signaling and increased activity of the transcription factor
forkhead box protein FOXO1 [15].
Decidualized cells deposit a dense extracellular matrix which
poses a physical barrier to trophoblast invasion, yet the decidua
with its resident leukocytes also provides a chemoattractant
microenvironment promoting invasion [16]. Decidualization
renders endometrial stromal cells more supportive to trophoblast
expansion [17]. Impaired decidualization has been linked to
defective embryo-maternal communication and recurrent preg-
nancy loss [18]. It is becoming increasingly clear that the decidua
is more than a passive matrix for the implanting blastocyst, is able
to sense embryo quality and may negate implantation of
compromised embryos [19,20]. Moreover, decidualized cells
themselves are motile and invasive and are envisaged to actively
support the profound tissue remodeling associated with implan-
tation and placentation [21–23]. Cytoskeletal reorganization of
decidualized endometrial stromal cells is regulated by Rho
GTPases and supports invasion of cocultured blastocysts in an
in-vitro implantation model [24,25].
Cell migration is fundamental to implantation, embryogenesis,
immune responses and wound healing. Locomotion can either be
random (chemokinesis; triggered by a uniformly present stimulus)
or directed (chemotaxis; following an external cue in a concen-
tration gradient) [26]. Both processes have been observed in
undifferentiated endometrial stromal cells in response to endo-
cannabinoids and shown to involve activation of the PI3K and
ERK1/2 pathways [27]. Endometrial stromal cells also mount a
motile response to the angiogenic growth factor PDGF-BB, a
phenomenon which may contribute to the regeneration of the
endometrial functional layer after menstruation [28]. Another
local growth factor with chemotactic activity is HB-EGF which
promotes differentiation of trophoblast cells to the invasive
phenotype [29,30]. Conditional deletion of uterine HB-EGF in
the mouse leads to impaired implantation, and an important role
of this factor in embryo-uterine communication is also suggested in
humans [31,32]. However, the effect of HB-EGF on endometrial
stromal cell motility has not been elucidated. Invasive trophoblast
secretes numerous factors potentially controlling endometrial/
decidual cell motility, however, these factors remain to be isolated.
Hence, the present study was undertaken to identify tropho-
blast-derived factors involved in the regulation of endometrial
stromal cell random and directed motility, and to further
characterize underlying signaling pathways.
Materials and Methods
Growth factors, cytokines, hormones, neutralizing
antibodies, inhibitors
Human recombinant HB-EGF, insulin, 17b-estradiol (E2) and
medroxyprogesterone acetate (MPA) were from Sigma-Aldrich
(Deisenhofen, Germany), PDGF-AA, placental growth factor
(PLGF-1), vascular endothelial growth factor (VEGF-165) from
Peprotech (Hamburg, Germany), and PDGF-BB from Biomol
(Hamburg, Germany). Neutralizing antibodies to HB-EGF (mouse
monoclonal, clone 406316) and PDGF (goat polyclonal, recogniz-
ing PDGF-AA, -AB, -BB) were from R&D Systems (Abingdon,
UK).
The following inhibitors were used: EGFR/ERBB2/ERBB4
(EGFR1/2/4) inhibitor (Calbiochem; Merck Chemicals, Darm-
stadt, Germany), AG1478 (tyrosine kinase inhibitor), Wortmannin
(PI3 kinase inhibitor), SB202190 (p38 inhibitor) (Sigma), Y27632
(inhibitor of Rho-associated, coiled-coil containing protein kinase;
ROCK), NSC23766 (Rac1 inhibitor) (Tocris, Bristol, UK),
PD98059 (MEK1/2 inhibitor), and LY294002 (PI3 kinase
inhibitor) (New England Biolabs, Frankfurt, Germany).
Cell Culture
Primary human endometrial stromal cells
(hESCs). Hysterectomy specimens were obtained from premen-
opausal women (operated for benign indications) with no history of
recurrent miscarriage and were taken randomly in the cycle. This
study was approved by the Medical Review Ethics Committee
University Medical Center Utrecht and the Central Committee on
Research involving Human Subjects in The Netherlands
(NL30143.000.09). Written informed consent was obtained from
all participating subjects. Endometrial tissues were processed and
hESCs isolated as previously described [22]. Cells were seeded in
phenolred-free Dulbecco’s modified Eagle medium (DMEM)/
Ham’s F12 (F12) supplemented with 1% amphotericin B (Sigma),
1% penicillin/streptomycin solution (Life Technologies, Paisley,
U.K.) and 10% heat-inactivated fetal bovine serum (FCS).
Individual hESC cultures were expanded to passage 2 and frozen
in aliquots at 2150uC.
Frozen hESCs were resuscitated and maintained in hESC
medium: phenolred-free DMEM/F12 with 10% steroid-depleted
dialysed FCS (PromoCell, Heidelberg, Germany), 100 U/ml
penicillin, 100 mg/ml streptomycin, and supplemented with
insulin (1 mg/ml) and E2 (1 nM). Decidualization was induced
in minimal medium 1 (MM1-2%; phenolred-free DMEM/F12
supplemented with 2% steroid-depleted FCS and antibiotics) by 5
d treatment with 0.5 mM 8-Br-cAMP (Biolog, Bremen, Germany)
and 1 mM MPA. Decidualization was assessed by RT-PCR for
expression of the marker genes PRL, IGFBP1 and FOXO1, and by
measurement of PRL and IGFBP-1 in culture supernatants (Figure
S1).
St-T1b and AC-1M88 cell lines. The telomerase-immortal-
ized human endometrial stromal cell line, St-T1b, has been
characterized previously [33]. Cells were maintained and decid-
ualized as described for primary hESCs.
The human trophoblast cell line AC-1M88, a hybridoma of
primary EVT from term placenta with a selectable mutant of the
JEG-3 choriocarcinoma cell line [34,35], was maintained in
DMEM/F12 with 10% complete FCS, 100 U/ml penicillin, and
100 mg/ml streptomycin. For preparation of trophoblast condi-
tioned medium (TCM), AC-1M88 cells were plated at a density of
4.26106 cells per 12 ml of culture medium in T25 cell culture
flasks. The next day, medium was replaced by MM1-10%
(composition as MM1-2% but containing 10% dialysed FCS) or
Opti-MEM reduced serum media (Life Technologies), depending
on the intended use of the conditioned media. The supernatant
was harvested 24 h later.
Generation of Conditioned Medium from Villous Explant
Cultures
Placental tissues of early pregnancy (between 6 and 11 weeks of
gestation) were obtained from legal abortions of uncomplicated
pregnancies. Utilization of tissues was approved by the ethical
Motility of Human Endometrial Stromal Cells
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committee of the Medical University of Vienna requiring informed
patient consent.
Placental villous explants of 2–3 mm in size were carefully
dissected from first-trimester placentae in pre-warmed culture
medium (serum-free DMEM/F12 supplemented with gentamycin
[50 mg/ml; Life Technologies, Paisley, U.K.]). Subsequently,
explants were incubated floating in culture medium overnight at
37uC, 5% CO2. The next day, rat-tail collagen Type I (BD
Biosciences, Bedford, MA), supplemented with 10x DMEM/low
glucose (1:10; Sigma) and 7.5% sodium bicarbonate (1:5; Sigma),
was poured to a 4 cm tissue culture dish. After formation of gels
(30 min at 37uC, followed by 10 min equilibration in culture
medium), 25 explants were placed on top of each humid collagen-
field and incubated for 5 h at 37uC to allow anchorage.
Subsequently, explants were supplemented with 4 ml culture
medium and incubated for 3–4 days at 37uC and 5% CO2 to allow
outgrowth of EVT. Upon harvesting, pooling and centrifugation
(5 min, 2000 g), the supernatant was snap frozen in liquid nitrogen
and stored at 280uC. These supernatants are designated as villous
explant conditioned media (VECM). As a control, culture medium
alone was incubated and stored as described above (VECM-Co).
Proteome Profiling Arrays
For preparation of conditioned medium from trophoblast or
endometrial stromal cell lines, AC-1M88 cells or pre-decidualized
St-T1b cells were suspended in MM1-2% and plated at a density
of 1.26106 cells/well in 6-well plates. The next day, medium was
replaced by 1.1 ml fresh MM1-2% and the supernatant harvested
24 h later. Aliquots were stored at 280uC for proteome analysis.
Proteome Profiler Array Kits (Human Cytokine Array Panel A, or
Human Angiogenesis Array) were purchased from R&D Systems
and applied according to the manufacturer’s instructions, using 1
ml conditioned medium (from villous explant cultures, AC-1M88
cells, or decidualized St-T1b cells) per membrane. The cytokine
array membrane carries capture antibodies to 36 factors, the
angiogenesis array membrane carries antibodies to 55 factors,
each spotted in duplicate. The samples were mixed with a cocktail
of biotinylated detection antibodies, allowed to bind to the
membranes, followed by several washes and incubation with
streptavidin-HRP and chemiluminescence reagent. After exposure
to film, signal intensities were quantified using ImageJ software.
Values for integrated densities of each spot were corrected for
background signal and normalized to positive control spots
contained on each membrane. After graphical plotting in Excel,
the X-axis was divided into three sections and values within the
lower, middle or upper third of the range were classified as weak
(+), medium (++) or strong (+++) signal, respectively.
Chemotactic Migration Assay
Directed migration was monitored by transwell migration assay,
using non-coated cell culture inserts with 8 mm pores for 24-well
recipient plates (BD Biosciences, Heidelberg, Germany). St-T1b
cells or hESCs were plated at a density of 36104 cells/insert in
350 ml Opti-MEM. The lower reservoir received 750 ml MM1-
10% without or with supposed chemoattractive factors, TCM
generated in MM1-10%, VECM, or VECM-Co. If inhibitors were
included in the assay, cells were suspended in 100 ml Opti-MEM,
allowed to attach to the insert for 3 h, then 250 ml of inhibitor in
Opti-MEM, diluted to achieve the intended final concentration,
was added and preincubated with the cells for 1 h. Then
chemoattractant in 750 ml MM1-10% was added to the lower
reservoir. Each treatment was performed in quadruplicate wells.
Migration was allowed to proceed for 18 h. Cells were fixed in
methanol for 2.5 min, followed by staining in solutions I and II
from the Diff-Quik Staining Kit (Siemens Healthcare Diagnostics,
Eschborn, Germany) for 2.5 min each. From three of the four
inserts, the non-migrated cells from the upper side of the
membrane were wiped off with a cotton swab, while from the
forth insert, the migrated cells on the lower side were removed. On
each membrane, cells were counted in six randomly selected visual
fields (106objective) and the mean number of cells per visual field
(N) was determined. Numbers of cells on the upper side (NU),
added to numbers of cells on the lower side (NL, mean from 3
membranes) yielded the total cell number (NT) per visual field.
The percentage of migrated cells, designated as the motility index,
was calculated as follows: motility index = NL/NT 6100. This
procedure takes into account that decidualization status or
addition of growth factors or inhibitors might affect viability or
proliferation rate during the migration period.
Chemokinetic Migration Assay
Non-directed migration was determined using the OrisTM Cell
Migration Assay (AMS Biotechnology, Abingdon, U.K.). Princi-
pally, a central silicon stopper is inserted into each well of a black
96-well culture plate with clear flat bottoms. The stopper prevents
cell attachment following cell seeding, creating a cell-free central
migration zone. St-T1b cells suspended in 100 ml MM1-10%
(46104 non-decidualized or 56104 decidualized cells) were plated
Figure 1. Chemotactic response of St-T1b cells or primary
hESCs to PDGF-BB, HB-EGF and trophoblast conditioned
medium. St-T1b cells (upper panel) or hESC (lower panel), non-
decidualized (ND) or decidualized (D) by 5 d treatment with 8-Br-cAMP/
MPA, were subjected to transwell migration assay. The bottom reservoir
contained MM1-10% (controls), PDGF-BB, HB-EGF or conditioned
medium (TCM) from the trophoblast cell line AC-1M88 undiluted
(100%) or diluted to 80% or 20%. The motility index designates the
percentage of migrated cells relative to the total cell number (non-
migrated plus migrated) at the end of the 18 h migration period. Shown
are results representative of 3 similar experiments (means6 SD, n = 3).
Data were analyzed by ANOVA and Dunnett post-hoc test. *, P,0.05;
**, P,0.01; *** P,0.001 compared to the respective control within the
ND or D groups.
doi:10.1371/journal.pone.0054336.g001
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in every well around the stoppers. Cells were allowed to attach for
4 h, then the stoppers were removed and the monolayers washed
free of debris. One-hundred ml fresh MM1-10% without or with
factors, or TCM generated in MM1-10%, were added. For
inhibitor studies, the monolayers were preincubated with 100 ml
MM1-10% supplemented with the inhibitors for 1 h after stopper
removal. Subsequently, 100 ml MM1-10% with factors were
added to achieve the desired final factor concentration. Cells
were permitted to migrate into the central detection zone for 18 h.
Each treatment was done in quadruplicate wells. Quantification of
cell migration was not performed according to the manufacturer’s
instructions but as detailed in the Supporting Information
(Protocol S1).
Western Blotting
Whole cell extracts were prepared in RIPA buffer (0.1% sodium
dodecylsulfate, 1% Triton X-100, 1% sodium deoxycholate,
150 mM NaCl, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4) with
complete protease inhibitors (Roche Applied Science, Mannheim,
Germany). Cells for short-term stimulations were plated in 12-well
plates, starved overnight in Opti-MEM, stimulated with factors
diluted in Opti-MEM (5–60 min, 24 h), and harvested in 60 ml
Quick Extract Buffer (QEB) heated to 85uC (2% sodium
dodecylsulfate, 10% glycerol, 0.1% bromophenol blue, 5% b-
mercaptoethanol, 50 mM Tris-HCl, pH 6.8). RIPA extracts (10–
30 mg protein/lane, mixed with loading buffer) or QEB extracts
(15 ml/lane) were electrophoresed on 10% or 4–12% SDS-
polyacrylamide gels (NuPage Bis-Tris; Invitrogen) and transferred
by tank-blotting onto polyvinylidene difluoride Immobilon mem-
branes (Millipore, Eschborn, Germany) as detailed previously [33].
Immunodetection was performed with the enhanced chemilumi-
nescence system (SuperSignal; Pierce, Bonn, Germany). Primary
antibodies were directed to: GAPDH (clone 6C5, 1:10,000;
HyTest, Turku, Finland), a-SMA (clone 1A4, 1:1000; Dako,
Hamburg, Germany), p38, phospho-p38, ERK1/2, Akt, phospho-
Akt(Ser473), MLC2, phospho-MLC2(Ser19) (all 1:1000; New
England Biolabs), phospho-ERK1/2 (1:2000; New England
Biolabs), HER4 (clone E200, 1:5000), Nur77 (clone EPR3209,
1:2000) (both from Epitomics, Burlingame, CA, USA), and HER1
(either: clone D38B1, 1:5000; New England Biolabs, or: #sc-03,
1:1000; Santa Cruz Biotechnology, Heidelberg, Germany).
Secondary antibodies (HRP-conjugated anti-mouse or anti-rabbit
IgG) were from Dianova (Hamburg, Germany).
Statistical Analysis
Data were analyzed by ANOVA followed by Tukey or Dunnett
post-hoc test, using GraphPad Prism software. Unless indicated
otherwise, each experiment was repeated at least three times and
figures reflect representative experiments with means 6 SD of
n= 3–4 replicates.
Results
Chemotactic response of endometrial stromal cells to
PDGF-BB, HB-EGF, and conditioned medium from the
trophoblast cell line AC-1M88
In an initial experiment, we investigated the chemotactic
response of the immortalized endometrial stromal cell line St-
T1b to PDGF-BB, HB-EGF and trophoblast conditioned medium
(TCM), harvested from the EVT cell line, AC-1M88 (Figure 1).
TCM stimulated chemotaxis of St-T1b cells in a dose-dependent
fashion, and PDGF-BB also elicited a marked migratory response,
Figure 2. Expression and regulation of HER1 in St-T1b cells and hESCs. (A) Effect of decidualization on HER1 expression. Whole cell extracts
from two individual hESC preparations or from St-T1b cells, non-decidualized (2) or decidualized (+), were immunoblotted for HER1 (antibody from
New England Biolabs), and for GAPDH as a loading control. In addition, the levels of Nur77, a-SMA, MLC2 and phospho-MLC2 were analyzed. (B, C, D)
Time-dependent downregulation of HER1 in response to HB-EGF or TCM. Non-decidualized (ND) or decidualized (D) St-T1b cells, maintained in Opti-
MEM, were incubated with PDGF-BB, HB-EGF or TCM (20 or 100%) for 5 min (B) or 5, 30 and 60 min (C) and subjected to Western Blot analysis for
HER1 (antibody from Santa Cruz). Decidualized St-T1b cells were stimulated with HB-EGF or TCM (100%) for 5, 30 and 60 min or 24 h (D) and
analyzed for HER1 by Western blotting (antibody from Santa Cruz), followed by immunoblotting for phospho-ERK1/2 and phosphorylated (Ser473)
and total Akt.
doi:10.1371/journal.pone.0054336.g002
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both in non-decidualized and decidualized cells. In contrast, HB-
EGF only caused a significant response in decidualized St-T1b
cells. Comparable results were seen with primary hESCs (Figure 1).
Because we consistently observed a stronger migratory effect of
HB-EGF on decidualized compared to undifferentiated endome-
trial stromal cells, we monitored expression of HB-EGF receptors
(HER1, HER4) by Western blot analysis (Figure 2A). Both in
hESCs and in St-T1b cells, HER1 expression was elevated upon
decidualization. HER4 was not detectable (data not shown;
function of the HER4 antibody was confirmed by detecting a
strong positive signal in the human breast cancer cell line, T47D).
As a marker of decidualization, we observed upregulation of the
orphan nuclear receptor Nur77, which has also recently been
identified as a modulator of mesenchymal stromal cell migration
[36,37]. As expected, a-SMA was downregulated in conjunction
with decidualization [14], as was another cytoskeletal protein,
MLC2, along with its phosphorylated form.
We then investigated whether HB-EGF might be a chemoat-
tractive component of TCM. Incubation of St-T1b cells with HB-
EGF resulted in rapid downregulation of HER1 within 5 min,
with no recovery over 60 min (Figure 2B,C,D). Incubation with
TCM, at the higher dose which had proven chemotactic activity,
also caused loss of HER1 with similar kinetics. These responses
were independent of decidualization. PDGF-BB was without effect
on HER1 expression (Figure 2B). In decidualized St-T1b cells,
HB-EGF and TCM both activated the Akt and ERK1/2
pathways, again with comparable kinetics (Figure 2D). Phosphor-
ylation of Akt (Ser473) occurred within 5 min and was nearly gone
by 30 min, whereas phosphorylation of ERK1/2 was also
maximal at 5 min but remained elevated for at least 60 min in
response to both stimuli. Activation of signaling subsided within
24 h, while HER1 protein levels remained suppressed.
The above findings strongly suggested the presence of HB-EGF,
or a related HER1 ligand, in TCM. To further investigate this in a
functional assay, chemotactic migration towards TCM was
assessed in the absence or presence of the tyrosine kinase inhibitor
AG1478, targeting HER1/HER4, or the EGFR/ERBB2/ERBB4
inhibitor, targeting HER1/HER2/HER4 (Figure 3A). While both
substances significantly reduced St-T1b migration in response to
HB-EGF, no effect on TCM-stimulated migration was seen.
Lastly, a neutralizing antibody to HB-EGF was employed at a
concentration sufficient to fully block chemotaxis towards HB-
EGF (Figure 3B). However, neutralization of HB-EGF did not
reduce TCM-stimulated migration. The bioneutralizing antibody
did not inhibit migration non-specifically, as chemotaxis towards
PDGF-BB was not affected.
Taken together, TCM is a powerful chemoattractant for
endometrial stromal cells. It contains a component that interacts
with HER1 and causes downregulation of the receptor. However,
TCM-induced migration does not seem to require activation of
HER1, HER2 or HER4, nor does it depend on the presence of
HB-EGF.
Chemotactic response of endometrial stromal cells to
conditioned medium from first trimester villous explant
cultures
Next, we wished to study the endometrial stromal cell migratory
response to the secretions of primary trophoblast cells. Villous
Figure 3. Effect of EGF receptor antagonists or HB-EGF
neutralizing antibody on chemotactic migration of St-T1b cells
or hESCs. (A) Decidualized St-T1b cells were preincubated in transwell
migration inserts with the tyrosine kinase inhibitor AG1478 (100 nM) or
the EGFR1/2/4 (HER1/HER2/HER4) inhibitor (10 nM) for 1 h before
addition of HB-EGF or TCM to the lower compartment for another 18 h.
The percentage of migrated cells relative to the total cell number is
given as the motility index (means6SD, n = 3). Results were analyzed by
ANOVA and Dunnett or Tukey test. ***, P,0.001 compared to the
respective control without inhibitor; a, P,0.001, b, P,0.01 compared to
non-stimulated cells without inhibitor (open column). (B) Decidualized
hESCs were subjected to transwell migration assay with PDGF-BB, HB-
EGF or TCM as the chemoattractant, in the absence or presence of a
neutralizing antibody to HB-EGF. Motility indices (means6SD, n = 3)
were analyzed by ANOVA and Tukey test. a, P,0.001 compared to the
control without chemoattractant or antibody (white column); ***,
P,0.001 compared between conditions without or with antibody.
doi:10.1371/journal.pone.0054336.g003
Figure 4. Chemotactic response of hESCs to conditioned
medium from first trimester villous explant cultures. Decidua-
lized hESCs were subjected to transwell migration assay using TCM, or
supernatants from three individual first trimester villous explant
cultures (VECM), as the chemoattractant (undiluted). The control
medium for TCM treatment was MM1-10%, that for VECM was serum-
free medium incubated with collagen as detailed in Materials &
Methods (VECM-Co). Motility indices represent means6SD (n = 3) and
were analyzed by ANOVA and Tukey test. ***, P,0.001 compared to the
respective control.
doi:10.1371/journal.pone.0054336.g004
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Table 1. Proteome profiling for cytokines and angiogenesis factors in conditioned medium from AC-1M88 human trophoblast
cells, two individual first trimester villous explant cultures, and the St-T1b human endometrial stromal cell line after decidualizing
treatment.














Angiogenin + ANG ( ) ++
Angiopoietin-2 + ANGPT2 EVT6, CTB+
Amphiregulin ++ + AREG ( )
CCL2 (MCP-1) CCL2 ( ) +++
CD105 (Endoglin) + ++ + ENG EVT+, CTB+
CD154 (CD40 Ligand) CD40LG ( ) +
CD26 (DPPIV) + +++ +++ DPP4 EVT+, CTB+ +
Coagulation Factor III (TF) + F3 ( )
CSF-2 (GM-CSF) CSF2 ( ) +
CXCL1 (GROa) ++ + CXCL1 EVT6, CTB6 ++
CXCL4 ++ PF4 ( )
CXCL16 ++ + CXCL16 not represented
Endostatin + + COL18A1
cleavage product
( )
ET-1 c ++ ++ EDN1 ( ) +
HGF ++ + HGF ( ) +
IFN-c IFNG ( ) +
IGFBP-1 +++ + IGFBP1 CTB6
IGFBP-2 +++ ++ IGFBP2 EVT6
IGFBP-3 +++ +++ IGFBP3 EVT+, CTB+ +++
IL-1ra IL1RN ( ) +
IL-6 +++ +++ IL6 EVT6, CTB+ +
IL-8 (CXCL8) +++ +++ IL8 CTB6 +++
IL-23 IL23A alpha-subunit ( ) +
Leptin +++ +++ LEP EVT+, CTB+
MIF +++ ++ + GLIF, MMIF EVT+, CTB+ +++
MMP-9 ++ ++ + MMP9 EVT+, CTB+ ++
PAI-1 (Serpin E1) +++ +++ +++ SERPINE1 EVT+, CTB+ +++
PDGF-AA +++ + PDGFA EVT6, CTB6
Persephin + PSPN ( )
PEDF (Serpin F1) + + + SERPINF1 EVT+, CTB+
PLGF (Placental GF) +++ ++ ++ PGF EVT+, CTB+
PRL PRL ( ) +
Prokineticin-1 ++ + PROK1 not represented
PTX3/TSG-14 + + PTX3 ( ) +
TGF-b1 (LAP) ++ + TGFB1
cleavage product
EVT+, CTB+
Thymidine Phosphorylase + TYMP EVT6, CTB6
TIMP-1 +++ +++ +++ TIMP1 EVT+, CTB+ +++
TIMP-4 + TIMP4 ( )
TSP-1 + THBS1 CTB6 +
uPA + PLAU EVT6, CTB6
VEGF +++ + + VEGFA EVT+, CTB+ +++
aProteome profiling: +, low; ++, medium; +++, strong signal intensity on Proteome Profiler Array membranes (cytokines and angiogenesis factors). Proteome profiles
were compared to b Microarray mRNA expression profiles of EVT and villous CTB as reported in http://www.ncbi.nlm.nih.gov/geoprofiles?term=GDS3523 [38].
EVT+, invasive extravillous trophoblast, all 6 mRNA pools gave positive signal; CTB+, non-invasive villous cytotrophoblast, all 5 mRNA pools gave positive signal; EVT6,
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explant conditioned media (VECM) from villi of three individual
placentae were employed in transwell migration assays with
decidualized hESCs (Figure 4). All three preparations significantly
stimulated chemotaxis over that seen with serum-free control
medium (VECM-Co). The stimulatory activity of the most potent
VECM was in the range of that seen with undiluted TCM from
AC-1M88 cells. Upon dilution, activity of the villous explant
samples was lost (data not shown), suggesting that concentration of
active components was at the lower limit.
Proteome profiling of secretions from AC-1M88
trophoblast cells and first trimester villous explant
cultures
In an attempt to identify candidate chemoattractive constitu-
ents, TCM (from AC-1M88 cells) and VECM from two individual
villous explant cultures were subjected to proteome profiling for
cytokines and angiogenesis factors. To identify cell- or tissue-
specific secretions, the TCM and VECM profiles were contrasted
to the profile of decidualized St-T1b cells (Table 1). In addition,
proteome profiles were compared to gene expression profiles
previously generated from isolated EVT and CTB primary
trophoblast populations [38]. While fewer factors were detected
in AC-1M88 supernatants than in villous supernatants, almost all
factors found in AC-1M88 supernatants were also present in
villous supernatants. Moreover, expression of these factors had
also been identified at the transcript level in purified EVT,
supporting the cellular origin of the AC-1M88 cell line. Only
coagulation factor III (tissue factor; TF) and tissue inhibitor of
metalloproteinases 4 (TIMP4) were detected in AC-1M88
supernatant but were neither present in VECM nor in the
transcript profiles of EVT or CTB. It should to be noted that a
number of cytokines and growth factors, including amphiregulin
(AREG), endothelin-1 (ET-1), hepatocyte growth factor (HGF), or
CXCL4, were picked up in the proteome profile of villous explant
supernatants while their expression had not been found at the
transcript level in purified EVT or CTB by Bilban et al [38]
(Table 1). This is underpinned by the absence of these mRNAs in
an independent genome-wide expression profiling of CTB and
EVT reported by Apps et al [39].
Numerous factors identified in the VECM proteome profile, but
not in AC-1M88 cells, appear to be of CTB origin, e.g. IGFBP-1,
IL-8 and TSP-1. IL-8 and TSP-1, in turn, were also products of
decidualized St-T1b cells and support their decidualization status,
as does the cell-specific expression of PRL. Among the prevalent
products common to AC-1M88 cells, villous explants and St-T1b
cells were macrophage migration inhibitory factor (MIF), matrix
metalloproteinase 9 (MMP-9), plasminogen activator inhibitor
(PAI-1), TIMP-1 and VEGF. Notably, neither PDGF-BB nor HB-
EGF were detectable in any of the samples.
For the ensuing experiments, we focused on two proteins that
were present in trophoblast cells and villous explants but absent
from St-T1b cells, namely PDGF-AA and placental growth factor
(PLGF), and on the ubiquitous factor VEGF.
Chemotactic response of endometrial stromal cells to
PDGF-AA, PLGF, and VEGF
Transwell migration of decidualized hESCs was assessed in
response to the trophoblast-specific secretory products, PDGF-AA
and PLGF, and to VEGF which was abundantly secreted by all
cell types (Figure 5A). PDGF-AA (at 100 ng/ml) stimulated
migration to an extent comparable to that of PDGF-BB (10 ng/
ml), HB-EGF (20 ng/ml), or undiluted TCM. PLGF and VEGF
(20 ng/ml) did not induce migration. Further experiments using
up to 100 ng/ml of these factors also yielded no response (data not
shown).
A neutralizing PDGF antibody, recognizing the PDGF-BB, -AB
and -AA dimers, was added at a dose sufficient to inhibit migration
stimulated by PDGF-AA (100 ng/ml) (Figure 5B,C). This
antibody did however not antagonize chemotaxis driven by
TCM or VECM, indicating that the chemotactic activity of
PDGF-AA in trophoblast secretions is redundant.
Chemokinetic response of endometrial stromal cells to
PDGF-BB, HB-EGF, TCM and PLGF
All factors tested in transwell migration assays, assessing
chemotaxis in response to a concentration gradient, were also
applied in an Oris migration assay to monitor random migration,
i.e. chemokinesis, in response to a homogeneously dissolved factor.
Only PDGF-BB significantly stimulated motility in this setting, in
non-decidualized as well as in decidualized St-T1b or primary
hESCs (Figure 6). In marked contrast to their chemoattractant
activity, TCM, HB-EGF or PDGF-AA failed to enhance
chemokinesis. PLGF and VEGF were again without effect.
Elucidation of signaling pathways involved in regulation
of chemotaxis or chemokinesis
The previous experiments revealed two groups of compounds:
those which exclusively functioned as chemoattractants (HB-EGF,
TCM, PDGF-AA) versus PDGF-BB which acted both as a
chemoattractant and as a stimulus for random motility. We
wondered if distinct signaling pathways were utilized by either
group of stimulants. All four compounds yielded a phosphorylation
of Akt and ERK1/2 in St-T1b cells and hESCs within 5 min
(Figure 7). Phosphorylation of p38 was faint and not consistently
seen. Activation of ERK1/2 in response to all four stimuli was
maintained over 30 min. Sustained activation of Akt was only
elicited with PDGF-BB while the responses to HB-EGF, TCM or
PDGF-AA returned to control level within 30 min. VECM only
yielded a very weak activation of ERK1/2 and p38 compared to
treatment with villous explant control medium (Figure 7 B).
We then tested effectiveness and specificity of signaling pathway
inhibitors by incubating decidualized St-T1b cells with inhibitors
prior to 5 min stimulation with PDGF-BB, TCM or IL-1b (used as
a robust stimulus for p38 activation) (Figure 8). SB202190
prevented phosphorylation of p38, the PI3K inhibitor Wortman-
nin ablated, and LY294002 blunted activation of Akt, the MEK1/
not all mRNA pools out of 6 gave positive signal; CTB6, not all mRNA pools out of 5 gave positive signal; ( ), not detected in EVT or CTB. c ET-1 protein was also detected
in villous explant control media (+) and may therefore not be a specific explant product. No signal was obtained in any of the cell types for the following factors
represented on the Proteome Profiler Array membranes for cytokines or angiogenesis factors: Activin-1, ADAMTS-1, Angiopoietin-1, Angiostatin, Artemin, CFS-3 (G-CSF),
EGF, FGF-1, FGF-2, FGF-4, FGF-7, GDNF, C5/C5a, CCL1, CXCL10, CXCL11, CD54 (sICAM-1), CXCL12, HB-EGF, IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IL-16, IL-17, IL-27,
IL-32a, MIP-1a, MIP-1b, MMP-8, NRG1-b1, PDGF-AB, PDGF-BB, RANTES (CCL5), Serpin B5 (Maspin), TNF-a, sTREM-1, TSP-2, Vasohibin, VEGF-C.
doi:10.1371/journal.pone.0054336.t001
Table 1. Cont.
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2 inhibitor PD98059 abolished ERK1/2 phosphorylation, and
ROCK inhibitor Y27632 reduced basal levels of phospho-MLC2.
Neither Rac1 inhibitor NSC23766 nor any other inhibitor
significantly interfered with other pathways within this short-term
stimulation. Wortmannin was chosen as PI3K inhibitor for further
experiments as it was more effective than LY294002.
The above inhibitors were then added to decidualized hESCs to
monitor the effect on basal or TCM-stimulated chemotaxis
(Figure 9). None of the inhibitors significantly reduced migration
towards TCM. However, basal migration was markedly affected;
inhibition of ERK1/2, PI3K/Akt, or p38 signaling diminished,
while the ROCK inhibitor vastly enhanced motility of hESCs.
Microphotographs of migrated cells at the underside of the porous
membrane are shown in Figure S2.
Chemokinesis was then assessed by Oris migration assay under
basal conditions, or under PDGF-BB stimulation (Figure 10A).
PI3K inhibitor reduced PDGF-BB-stimulated migration, while
ROCK inhibitor markedly enhanced both basal and stimulated
migration of decidualized St-T1b cells. The appearance of
migrated cells in the detection zone of the assay is illustrated in
Figure 10B. ROCK inhibitor caused the cells to produce
excessively long protrusions. This appearance clearly differed
from that seen in the presence of PDGF-BB, although both
compounds shared the ability to stimulate random and chemo-
tactic migration (Figure S3).
Taken together, the ERK1/2, PI3K/Akt and p38 signaling
pathways are involved in chemotactic motility, whereas chemo-
kinesis requires primarily PI3K/Akt activation. ROCK signaling
is inhibitory to both chemokinesis and chemotaxis.
Discussion
Extensive crosstalk at the fetal-maternal interface orchestrates
implantation and formation of the human placenta. It is widely
accepted that trophoblast cells, particularly interstitial and
endovascular EVT, follow chemoattractive gradients when invad-
ing the decidua and entering the maternal arteries [16]. The
results of our present study provide novel evidence to the concept
that decidual cells are likewise harnessed to migrate in response to
local stimuli. We propose that decidualized endometrial stromal
cells actively support the remodeling processes necessary for the
establishment and maintenance of pregnancy.
Here we demonstrate a strong motile response of endometrial
stromal cells to the angiogenic growth factor PDGF-BB. While we
did not detect PDGF-BB in the supernatants of AC-1M88
trophoblast cells or first trimester villous explants, the factor has
been found in uterine fluid taken from women in the receptive
phase of the menstrual cycle [40]. PDGF-BB immunoreactivity
has been localized to endometrial endothelial cells and vascular
smooth muscle cells throughout the cycle, while endometrial
stromal cells are positive for the receptor forms PDGF-Ra and -
Rb [41]. Undifferentiated hESCs have previously been shown to
mount a variety of responses to PDGF-BB including enhanced
contractility, migration, invasion and proliferation. This was
suggested to aid in tissue repair after menstruation [42]. We show
here that decidualized endometrial stromal cells likewise migrate
upon exposure to PDGF-BB. Interestingly, of all factors investi-
gated in the present study, PDGF-BB was the only one to induce
not only chemotaxis but also chemokinesis. It may therefore serve
to generally enhance motility of endometrial stromal cells without
directing them towards a particular location. This was in marked
contrast to the effect of PDGF-AA which solely functioned as a
chemoattractant. We found PDGF-AA to be secreted by the
trophoblast cell line AC-1M88 and by first trimester villous
Figure 5. Chemotactic response of hESCs to trophoblast
secretory products identified by proteome profiling. (A)
Decidualized hESCs were analyzed in transwell migration assay in
response to PDGF-BB, HB-EGF, TCM, PDGF-AA, PLGF-1 or VEGF-165.
Motility indices are shown as means6SD (n = 3), and were analyzed by
ANOVA and Dunnett test. ***, P,0.001 compared to the control
without chemoattractant. (B, C) Effect of neutralization of PDGF activity.
Decidualized hESCs were subjected to transwell migration assay with
two different doses of PDGF-AA (B) or with TCM and two individual
VECM preparations (C) in the absence or presence of a neutralizing
antibody to PDGF-AA/-AB/-BB (pan). Motility indices are shown as
means6SD (n = 3) and were analyzed by ANOVA and Dunnett or Tukey
test. ***, P,0.001; **, P,0.01 in the absence vs. presence of antibody. a,
P,0.001; b, P,0.01; c, P,0.05 compared to the respective control
without stimulation or antibody (white or light grey columns).
doi:10.1371/journal.pone.0054336.g005
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explants. The mRNA for PDGF-AA has also been demonstrated
in trophectoderm from day 5 implantation-competent blastocysts
while the corresponding receptor expression was seen in the
receptive endometrium [43]. It is thus conceivable that blastocyst-
derived PDGF-AA participates in attracting decidualizing endo-
metrial stromal cells to the implantation site. Attracted cells then
move around the implanting conceptus to engulf it, a process
which we have recently documented by time-lapse video recording
of decidualized hESCs cocultured with day 5 human embryos
[22].
Another powerful chemoattractant was HB-EGF. It specifically
stimulated migration of decidualized endometrial stromal cells,
which may in part be due to upregulation of the HER1 receptor
upon decidualization as we report here. While others have shown
both HER1 and HER4 in cultured hESCs [32,44], we only
detected the HER1 form by Western blotting. Incubation with
TCM or villous explant CM led to a profound and sustained
downregulation of HER1 in endometrial stromal cells, very similar
to that seen upon HB-EGF treatment. HER1 undergoes ligand-
induced endocytosis and, depending on the ligand, recycling or
degradation [45,46]. The receptor is recycled upon binding of
EGF, amphiregulin, TGFa or epiregulin, whereas HB-EGF and
betacullin target HER1 for lysosomal degradation [47]. While
HER1 in endometrial stromal cells was rapidly downregulated
upon HB-EGF treatment, ERK1/2 activation persisted for at least
one hour. Enhanced migration apparently results from HB-EGF
triggering a signaling network the downstream components of
which are largely independent of continued HER1 expression/
activation. The effectors may include secondary response genes
such as those encoding MMPs or cytokines as detailed in
comprehensive maps of EGF receptor signaling [48–50].
In TCM or villous explant supernatants, HB-EGF was below
the level of detection, and adding antagonists to HER1, HER2
and/or HER4 to migrating endometrial stromal cells did not
diminish their response to TCM while effectively blocking that to
isolated HB-EGF. Our data suggest that not HB-EGF but another
as yet unidentified HER1 ligand is prominently present in TCM;
yet this ligand does not exert a major contribution to the
chemoattractant activity of TCM. It has been reported that the
proteoglycan decorin binds to HER1 and evokes internalization
Figure 6. Chemokinetic response of St-T1b cells or primary hESCs to PDGF-BB, HB-EGF, TCM and trophoblast secretory products
identified by proteome profiling. St-T1b cells (upper panel) or hESC (lower panel), non-decidualized (ND) or decidualized (D), were subjected to
Oris migration assay to monitor random motility, in the presence of PDGF-BB, HB-EGF, TCM, PDGF-AA, PLGF-1, or VEGF-165 at the indicated
concentrations. Numbers of cells that had migrated into the detection zone after 18 h incubation were determined and normalized to unstimulated
controls within each ND or D group. Shown are the means6SEM of n = 3 independent experiments. Results were analyzed by ANOVA and Dunnett
test within each group. ***, P,0.001; **, P,0.01 compared to untreated controls (white columns).
doi:10.1371/journal.pone.0054336.g006
Motility of Human Endometrial Stromal Cells
PLOS ONE | www.plosone.org 9 January 2013 | Volume 8 | Issue 1 | e54336
and degradation of the receptor via caveolar-mediated endocytosis
[51]. We therefore reasoned that decorin might be present in
TCM. Western blot analyses, however, revealed decorin produc-
tion and secretion by St-T1b cells and hESCs and up-regulation
upon decidualization, but the proteoglycan was not detectable in
trophoblast cell supernatants (data not shown).
HB-EGF has been recognized as a crucial mediator of embryo-
uterine interactions in the mouse [32]. In humans, the growth
factor is detected in uterine fluid aspirated immediately prior to
embryo transfer in natural and stimulated cycles [52]. Endometrial
expression peaks in the luminal and glandular epithelium at the
time of implantation, while stromal expression decreases in the
mid-secretory phase [53–57]. HB-EGF has been ascribed a role in
promoting decidualization and survival of hESCs [44]. Although
we did not detect HB-EGF secretion by the St-T1b endometrial
stromal cell line, primary hESCs have been documented to
produce HB-EGF in culture [44] and respond to the presence of a
compromised embryo with decreased HB-EGF secretion [19]. In
early pregnancy, HB-EGF is abundant in the decidua [58]. Our
data suggest that local HB-EGF not only promotes invasion of
trophoblast [29,30] but may also participate in modulating
endometrial stromal cell dynamics.
Our proteome profiling search for pro-migratory candidate
factors in TCM and villous explant supernatants led to the
identification of PDGF-AA, as mentioned above, and of VEGF
and PLGF which both belong to the family of vascular endothelial
growth factors. While the most common VEGF isoform, VEGF-A,
binds to VEGF-R1 (FLT1) and, albeit with lower affinity, to
VEGF-R2 (FLK1), PLGF selectively binds to VEGF-R1 [59].
VEGF-A and both receptor types are found in stromal, epithelial,
endothelial and vascular smooth muscle cells of the endometrium
throughout the cycle [59]. While VEGF-A is a certified stimulus of
migration in various cell types including endothelial, mesenchymal
and trophoblast cells [60–62], it did not elicit a migratory response
of endometrial stromal cells in our study. This may partly be
attributed to the fact that the cells themselves produced copious
amounts of the factor, as revealed by proteome profiling.
Moreover, VEGF action may be antagonized by the soluble form
of VEGF-R1, sFLT1 [63]. PLGF has long been recognized as a
prominent angiogenic trophoblast product [64]. Pertaining to the
earliest stages of human pregnancy, PLGF mRNA was also
detected in trophectoderm of day 5 blastocysts [43]. However, like
VEGF, PLGF failed to stimulate endometrial stromal cell
migration in our study. Again, this could be due to the production
of saturating amounts of VEGF, or of antagonizing sFLT1 by the
cultured cells. By RT-PCR, we detected transcripts for full length
VEGF-R1 as well as two variants of sFLT1 (sFLT1-i13 and
sFLT1-e15a) [65] in hESCs and St-T1b cells (data not shown),
although we did not substantiate this at the protein level. In vivo, it
will likely be the balance of pro-migratory VEGF and/or PLGF,
and antagonizing sFLT1, and the presence of chemotactic
gradients at the fetal-maternal interface, which will dictate extent
and direction of migration in the numerous target cells.
Access to early placental tissues is limited, and procurement of
sufficient numbers of purified trophoblast cells difficult as these
primary cells rapidly cease to proliferate in culture. For large scale
experiments, one therefore has to resort to cell lines with all
inherent limitations [66]. The EVT-derived cell line AC-1M88
Figure 7. Signaling pathways activated by PDGF-AA, PDGF-BB, HB-EGF, TCM, or VECM. (A) Decidualized St-T1b were starved in Opti-MEM
and then treated for 5 or 30 min with PDGF-BB, HB-EGF, TCM or PDGF-AA. Levels of phosphorylated (p-) or total ERK1/2, Akt, and p38 were
determined by Western blotting. (B) Decidualized hESC were starved in Opti-MEM and then treated for 5 min with PDGF-BB, HB-EGF, TCM, 5
individual VECM preparations, villous explant control medium (VECM-Co), or PDGF-AA. Western blotting was performed as above.
doi:10.1371/journal.pone.0054336.g007
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that we have chosen for our study has been designated an
acceptable surrogate for primary cells for the study of adhesion,
migration and invasion [67]. Our proteome profiling results
further support the validity of this cell line. Almost all AC-1M88
secretory products were also present in supernatants of first
trimester villous explant cultures. On the other hand, villous
explants were found to produce a much broader spectrum of
cytokines and angiogenesis factors, many of which could be
attributed to the expression of the corresponding genes in either
EVT or CTB. Additional sources may be the syncytiotrophoblast
or the mesenchymal villous core. Although villous explant CM
thus contained a much richer factor cocktail compared to TCM, it
tended to be less chemoattractive to endometrial stromal cells.
This may partly be due to the presence of inhibitory components
like endostatin, ET-1, endoglin, TGF-b, PAIs and TIMPs (see
Table 1) or additional inhibitory factors not covered by the
spectrum of the proteome profiling arrays used in this study,
including Dickkopf, Nodal or KISS10 [6].
In our attempt to dissect the signaling pathways relevant to
random or chemotactic migration, we observed a reduction of
basal chemotaxis (i.e. towards 10% steroid-depleted FCS in the
lower compartment of the transwell chambers) upon inhibition of
ERK1/2, p38 or PI3K signaling. The involvement of ERK1/2
and PI3K/Akt signaling in endometrial stromal cell chemotaxis, in
response to PDGF-BB, has previously been reported [28]. No
single inhibitor, however, markedly reduced migration towards
TCM, suggesting the activation of multiple, partially redundant
pathways by the trophoblast secretions. When assessing random
migration in the presence of a uniform signal by means of the Oris
migration assay (similar to the well-known scratch or wound
healing assay), the PI3K pathway turned out to be essential for
PDGF-BB stimulated motility.
Migration depends on cytoskeletal fluidity and continuous
destabilization and stabilization of cortical actin stress fibers.
ROCK1 activation by the Rho GTPase RhoA results in increased
MLC phosphorylation, generating contractile forces through
actin-myosin interactions [68]. Lamellipodial protrusions at the
leading edge provide integrin-mediated adhesion to the underlying
substrate. Contraction and detachment of trailing edges then allow
promotion of the cell body [26]. Blocking Rho activity, which
reduces ROCK1 activity, has been observed to increase lamelli-
podium extension, possibly by counteracting contraction [69]. In a
coculture model of blastocysts on a monolayer of decidualized
hESCs, motility of the stromal cells was found mandatory for
blastocyst invasion. The outgrowth of blastocysts was enhanced by
silencing of RhoA in the stromal cells, indicating an anti-invasive
role of RhoA [24,25]. Silencing of Raf-1, a serine/threonine
kinase upstream of the MEK/ERK pathway [70], inhibits the
migration of hESCs and coincides with increased ROCK activity,
suggesting that excessive ROCK activity attenuates migration
[71]. These studies fit well with our observation of enhanced
Figure 8. Functional validation of pathway inhibitors. Decid-
ualized St-T1b were preincubated for 1 h with Y27632 (100 mM),
NSC23766 (50 mM), Wortmannin (200 nM) (A) or PD98059 (50 mM),
LY294002 (10 mM), SB202190 (10 mM) (B), followed by 5 min stimulation
with PDGF-BB, TCM or IL-1b. Control cultures received Opti-MEM. Total
or phosphorylated (p-) Akt, p38, ERK1/2 and MLC2 were detected by
Western blot analysis.
doi:10.1371/journal.pone.0054336.g008
Figure 9. Effect of pathway inhibitors on chemotactic migra-
tion of hESCs. Decidualized hESCs in transwell migration inserts were
preincubated with PD98059 (50 mM), Y27632 (100 mM), NSC23766
(50 mM), SB202190 (10 mM) or Wortmannin (200 nM) before the
addition of TCM to the lower reservoir. Controls received MM1-10%
instead of chemoattractant. Motility indices are means6SD (n = 3) and
were analyzed by ANOVA and Dunnett test. **, P,0.01; ***, P,0.001
compared to cells without inhibitor in the group without chemoat-
tractant (white column). No significant differences were seen within the
group receiving TCM. Exemplary images of migrated cells are shown in
Figure S2.
doi:10.1371/journal.pone.0054336.g009
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endometrial stromal cell motility in the presence of ROCK
inhibition, downstream of RhoA.
In our experiments, ROCK inhibition strikingly promoted
random motility in the absence or presence of PDGF-BB. The
ROCK inhibitor Y27632 also enhanced basal chemotaxis but did
not further augment chemotaxis elicited by TCM. Interestingly,
ROCK inhibition caused a rapid decrease in MLC2 phosphor-
ylation. Likewise, decidualization concurred with sustained
diminishment of total, and consequently, of phospho-MLC2.
Increased phosphorylation of MLC, vice versa, prevents in vitro
decidualization [72]. A negative role of elevated phospho-MLC2
in decidual cell migration is further supported by our observation
that decidualized cells consistently displayed higher basal migra-
tion than did undifferentiated endometrial stromal cells.
With the exception of ROCK inhibitor, PDGF-BB was the only
stimulus that activated stromal cell motility without providing
directional information. PDGF-BB binding leads to PDGFRb
endocytosis and Rac1 activation at the cell membrane [73].
Because Rac1 antagonizes Rho activity [74], PDGF-BB could thus
indirectly cause ROCK inhibition which contributes to enhanced
motility. In terms of signaling activity, PDGF-BB stood apart from
the chemotactic stimuli HB-EGF, PDGF-AA or TCM in its ability
to cause sustained activation of Akt. This is in accordance with our
finding that inhibition of the PI3K/Akt pathway was decisive in
ablating chemokinesis.
The ability of decidual cells for random migration, in addition
to directed movement towards trophoblast-derived signals, might
aid in tissue remodeling at the implantation site. Decidualized
hESCs produce MMPs and are invasive [21,75] and could thus
generate proteolytic tracks in the extracellular matrix to facilitate
trophoblast invasion, analogous to fibroblast-led collective invasion
of tumor cells [76].
In summary, our study described the function of PDGF-BB,
HB-EGF and trophoblast-derived PDGF-AA in regulating endo-
metrial stromal cell motility and provides further evidence for the
active role of decidualized endometrial stromal cells in implanta-
tion and early pregnancy.
Supporting Information
Figure S1 Induction of decidualization markers in
hESCs and St-T1b cells. (A) Induction of transcripts for
PRL, IGFBP-1 and FOXO1 upon decidualizing treatment (5d 8-
Br-cAMP/MPA) was monitored by RT-PCR in two individual
primary hESC cultures, and in the St-T1b human endometrial
stromal cell line. (B) PRL and IGFBP-1 were measured by ELISA
in culture supernatants after 5 or 7 d of decidualizing treatment.
Secretion was normalized to RNA or protein content of the
monolayer. Values are means6SD from 2–3 replicates. PRL
secretion by St-T1b cells was mostly below the limit of detection
(nd, not detectable). Methods: RNA was extracted and reverse-
transcribed as detailed previously, and primer sequences and PCR
conditions for amplification of transcripts for decidual PRL,
IGFBP1, FOXO1 and GAPDH have been given elsewhere [33].
PCR products were resolved in 2% agarose gels and visualized by
SYBR Gold staining (Molecular Probes/Life Technologies). PRL
and IGFBP-1 secretion were assayed by ELISA kits from IBL
International (Hamburg, Germany) and Mediagnost (Reutlingen,
Germany), respectively, and normalized to total protein or RNA
harvested from the underlying monolayer.
(TIF)
Figure S2 Effect of pathway inhibitors on the appearance
of hESCs in chemotactic migration assays. Decidualized
hESCs in transwell migration inserts were preincubated for 1 h with
MEK1/2 inhibitor PD98059 (50 mM), ROCK inhibitor Y27632
(100 mM), Rac1 inhibitor NSC23766 (50 mM), p38 inhibitor
SB202190 (10 mM) or PI3K inhibitor Wortmannin (200 nM)
before the addition of trophoblast conditioned medium (TCM) to
the lower reservoir for 18 h. Controls received MM1-10% instead
of chemoattractant. Representative micrographs of migrated cells
on the underside of the inserts are shown (Diff-Quik staining, 106
objective). The 8 mm pores in the membranes are seen as dots.
(TIF)
Figure S3 Effect of pathway inhibitors on the appearance
of St-T1b cells in chemokinetic migration. Decidualized St-
Figure 10. Effect of pathway inhibitors on chemokinetic
motility of St-T1b cells. (A) Decidualized St-T1b cells were seeded
in Oris migration plates and preincubated with inhibitors for 1 h:
PD98059 (50 mM), Y27632 (100 mM), NSC23766 (50 mM), SB202190
(10 mM) or Wortmannin (200 nM). Then PDGF-BB was added to the
indicated final concentration, or the equivalent volume of control
medium, and cells allowed to migrate into the detection zone for 18 h.
Numbers of migrated cells were normalized to the control in the
absence of stimulus and inhibitor (left white column). Results represent
the means6SEM of n = 3 independent experiments. Data were analyzed
by ANOVA and Dunnett test within each group (unstimulated or treated
with PDGF-BB) and revealed significant differences after inhibitor
treatment compared to the respective controls without inhibitor:
*, P,0.05; **, P,0.01; *** P,0.001. (B) Representative images of
detection zones for the treatments evaluated in panel (A), showing cells
that had migrated into the cell-free zone within 18 h. Cells were stained
with Diff-Quik. Images of each detection zone were reassembled from 4
microphotographs taken with a 46 objective and graphically overlaid
with the black mask.
doi:10.1371/journal.pone.0054336.g010
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T1b cells were seeded at low density in chamber slides. Following
1 h preincubation with ROCK inhibitor Y27632 (100 mM) or PI3K
inhibitor Wortmannin (200 nM), monolayers were treated with
control medium or PDGF-BB (10 ng/ml). Eighteen hours later, cells
were fixed and stained with Diff-Quik. Microphotographs were
taken with a 206 objective. Note the extremely long protrusions
formed in response to ROCK inhibition.
(TIF)
Protocol S1 Quantification of migrated cells in the
OrisTM cell migration assay for chemokinesis.
(PDF)
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